SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
May 24, 2004
------------------------------------------------
Date of Report (date of earliest event reported)
Zynex Medical Holdings, Inc.
----------------------------------------------------
Exact Name of Registrant as Specified in its Charter
Nevada 33-26787-D 87-0403828
- --------------------------- --------------- ----------------------
State or Other Jurisdiction Commission File IRS Employer Identifi-
of Incorporation Number cation Number
8100 South Park Way, Suite A-9
Littleton, Colorado 80120
----------------------------------------------------
Address of Principal Executive Offices Zip Code
(303) 703-4906
------------------------------
Registrant's Telephone Number,
Including Area Code
Not Applicable
-------------------------------------------
Former Name or Former Address, if Changed
Since Last Report
ITEM 4. CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT
On May 24, 2004, Zynex Medical Holdings, Inc. (the "Company") engaged
Gordon Hughes & Banks, LLP to serve as the Company's independent accountants.
Also on May 24, 2004, Chisholm, Bierwolf & Nilson, LLC was dismissed as the
Company's independent accountants. The decision to engage Gordon Hughes &
Banks, LLP was made solely by the Company's Board of Directors. The Company
does not currently have an audit committee.
Chisholm, Bierwolf & Nilson, LLC became the Company's independent
accountants on February 10, 2004 as a result of a merger of the Company's
prior independent accountants. The change of independent accountants on
February 10, 2004 was reported in the Company' Report on Form 8-K dated
February 10, 2004. As a result of the short time period it served as the
Company's independent accountant, Chisholm, Bierwolf & Nilson, LLC did not
issue any reports on the Company's financial statements. During the period
from February 10, 2004 through May 24, 2004, there were no disagreements with
Chisholm, Bierwolf & Nilson, LLC on any matter of accounting principles or
practices, financial statement disclosure, or auditing scope or procedure, or
other reportable event (of the type described in Item 304 (a) (1) (B) of
Regulation S-B)which disagreement(s), if not resolved to the satisfaction of
Chisholm, Bierwolf & Nilson, LLC, would have caused it to make reference to
the subject matter of the disagreement(s) in connection with a report.
During the years ended December 31, 2003 and 2002 and the subsequent
periods prior to engaging Gordon Hughes & Banks, LLP, neither the Company nor
anyone on its behalf consulted Gordon Hughes & Banks, LLP regarding either the
application of accounting principles to a specified transaction, either
completed or proposed, or the type of audit opinion that might be rendered on
the Company's consolidated financial statements, and neither a written report
nor oral advice was provided to the Company by Gordon Hughes & Banks, LLP.
The Company provided a copy of the disclosures contained herein to
Chisholm, Bierwolf & Nilson, LLC and requested that they provide a letter,
addressed to the Securities and Exchange Commission stating whether it agrees
with the statements made herein, and, if not, stating the respects in which it
does not agree. That letter is filed herewith as Exhibit 16.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
(c) EXHIBITS.
16 - Letter from Chisholm, Bierwolf & Nilson, LLC
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this Report to be signed on its behalf by the
undersigned, hereunto duly authorized.
ZYNEX MEDICAL HOLDINGS, INC.
Dated: May 24, 2004 By:/s/ Thomas Sandgaard
Thomas Sandgaard, President
2